K. Rithidech et al., HYPERMUTABILITY OF MOUSE CHROMOSOME-2 DURING THE DEVELOPMENT OF X-RAY-INDUCED MURINE MYELOID-LEUKEMIA, Proceedings of the National Academy of Sciences of the United Statesof America, 92(4), 1995, pp. 1152-1156
In an effort to identify the precise role of a deletion at regions D-E
of mouse chromosome 2 [del2(D-E)] during the development of radiation
-induced myeloid leukemia, we conducted a serial sacrifice study in wh
ich metaphase chromosomes were examined by the G-banding technique. Su
ch metaphase cells were collected from x-irradiated mice during the pe
riod of transformation of some of the normal hematopoietic cells to th
e fully developed leukemic phenotype. A group of 250 CBA/Ca male mice
(10-12 weeks old) were exposed to a single dose of 2 Gy of 250-kilovol
t-peak x-rays; 42 age-matched male mice served as controls. Groups of
randomly selected mice were sacrificed at 20 hr, 1 week, and then at i
ntervals of 3 months up to 24 months after x-irradiation. Slides for c
ytogenetic, hematological, and histological examination were prepared
for each animal at each sacrifice time. An expansion of cells with les
ions on one copy of chromosome 2 was evident in 20-25% of treated mice
at each sacrifice time. The majority of such lesions were translocati
ons at 2F or 2H, strongly suggesting hypermutability of these sites on
mouse chromosome 2. No lesions were found in control mice. The findin
g leads to the possibility that genomic lesions close to 2D and 2E are
aberrants associated with radiation leukemogenesis, whereas a single
clone of cells with a del2(D-E) may lead directly to overt leukemia. T
he data also indicate that leukemic transformation arises from the cum
ulative effects of multiple genetic events on chromosome 2, reinforcin
g the thesis that multiple steps of mutation occur in the pathogenesis
of cancer.